1426833-68-2

Upstream product

• 1426833-58-0 1-[5-O-(4-methoxytrityl)-2-deoxy-2-vinyl-β-D-ribo-pentofuranosyl]-thymine 
• 1098973-98-8 1-(2-deoxy-2-iodo-β-D-ribofuranosyl)-5-methyluracil 
• 1426833-64-8 C₃₃H₅₂N₂O₉Si₂ 
• 26879-47-0 1-(β-L-ribofuranosyl)thymine 
• 22423-26-3 O-2,2'-cyclo-5-methyluridine 
• 1426833-59-1 1-[5-O-(4-methoxytrityl)-3-O-Benzyl-2-deoxy-2-vinyl-β-D-ribo-pentofuranosyl]thymine 
• 532-32-1 sodium benzoate 
• 1426833-65-9 1-[3-O-benzyl-4-C-hydroxymethyl-2-deoxy-2-acetoxymethyl-3-β-ribo-pentofuranosyl]thymine 
• 1426833-63-7 1-[4’,5‘-(1,1,3,3-tetraisopropyldisiloxane1,3-diyl)-3-O-benzyl-2-deoxy-2-hydroxymethyl-3-β-ribo-pentofuranosyl]thymine 
• 1426833-62-6 1-[4’,5‘-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-3-O-benzyl-2-deoxy-2-vinyl-β-D-ribo-pentofuranosyl]thymine 
• 1426833-61-5 1-[3-O-benzyl-4-C-hydroxymethyl-2-deoxy-2-vinyl-3-β-ribo-pentofuranosyl]thymine 
• 1426833-60-4 1-[3-O-benzyl-2-deoxy-2-vinyl-β-D-ribo-pentofuranosyl]thymine 
• 1426833-54-6 1-[5-O-(4-methoxytrityl)-2-deoxy-2-iodo-β-D-ribofuranosyl] 5-methyluracil 
• 1426833-56-8 1-[5-O-(4-methoxytrityl)-2-deoxy-2-iodo-3-(dimethyl)vinylsilyl-β-D-ribo-pentofuranosyl]-thymine 

Downstream Products

• 1426833-67-1 (1S,3R,4R,8S)-8-benzyloxyoxy-1-hydroxymethyl-3-(thymin-yl)-2,6-dioxabicyclo[3,2,1]octane 
• 226214-56-8 (1S,3R,4R, 8S)-8-hydoxy-1-(4,4’-dimethoxytrityloxymethyl)-3 (thymin-yl)-2,6-dioxabicyclo[3,2,1]octane 
• 226214-58-0 (1S,3R,4R,8S)-1-(4,4’-dimethoxytrityloxymethyl)-3-(thymin-yl)-2,6-dioxabicyclo[3,2,1]octane8-O-(2-cyanoethyl-N,N-diisopropylphosphoroamidite) 
• 1426833-69-3 (1S,3R,4R, 85)-8-triethylsilyloxy-1-(4,4’-dimethoxytrityloxymethyl)-3-(N4-thymin-yl)-2,6-dioxabicyclo[3,2,1]octane 
• 1426833-70-6 (1S,3R,4R,8S)-8-triethylsilyloxy-1-(4,4’-dimethoxytrityloxymethyl)-3-(N4-benzoyl-5-methylcytosin-yl)-2,6-dioxabicyclo[3,2,1]octane 
• 1426833-71-7 (1S,3R,4R,8S)-8-triethylsilyloxy-1-(4,4’-dimethoxytrityloxymethyl)-3-(N4-benzoyl-5-methylcytosin-yl)-2,6-dioxabicyclo[3,2,1]octane8-O-(2-cyanoethyl-N,N-diisopropylphosphoroamidite) 

Relevant academic research and scientific papers

SYNTHESIS AND USES OF NUCLEIC ACID COMPOUNDS WITH CONFORMATIONALLY RESTRICTED MONOMERS

Synthesis and uses of conformationally restricted nucleomonomers (CRN) to prepare nucleic acid compounds. Methods for preparing nucleomonomers for nucleic acid compounds in high yields and in multi-gram scale for therapeutic modalities useful for treating or preventing diseases or disorders by up- or down-regulating the expression of genes and other nucleic acid based regulatory systems in a cell.